Peter Lynch fit · Growth at a reasonable price (GARP)
Is TG Therapeutics, Inc. (TGTX) a Peter Lynch Stock?
Does not fit Lynch's GARP criteria — growth too low or price too high.
15/100
FNot a fit
2/6 criteria passed
Peter Lynch's Criteria, Applied to TGTX
PEG ≤ 1.0
key—
EPS CAGR ≥ 15%
key0.0%
Revenue CAGR ≥ 10%
-7.6%
Net margin > 0
84.1%
How TGTX Scores on Other Strategies
Live Financial Snapshot
Market cap
$5.02B
P/E (TTM)
191.1x
ROIC (TTM)
7.85%
Gross margin
85.33%
Frequently Asked Questions
What is TGTX's Peter Lynch fit score?
TGTX scores 15/100 on our Peter Lynch fit engine — grade F. Does not fit Lynch's GARP criteria — growth too low or price too high.
Does Peter Lynch actually own TGTX?
Our score is computed from financial fundamentals against Peter Lynch's published criteria. We don't claim that Peter Lynch personally owns or recommends TGTX.
How often is this score updated?
TGTX's Peter Lynch fit score is recomputed daily from the latest TTM financials.
Educational tool, not investment advice. Scores are computed from publicly-available financial data against published investing-strategy criteria. We do not claim that Peter Lynch personally owns or recommends TGTX.